{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:37:30Z","timestamp":1790019450399,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jpsychores.2022.111122","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:29:41Z","timestamp":1671190181000},"page":"111122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Symptoms that remain after depression treatment in patients with coronary heart disease"],"prefix":"10.1016","volume":"165","author":[{"given":"Robert M.","family":"Carney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Steinmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychores.2022.111122_bb0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0b013e31820ebd2c","article-title":"Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication","volume":"31","author":"McClintock","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychores.2022.111122_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4088\/JCP.v60n0403","article-title":"Residual symptoms in depressed patients who respond acutely to fluoxetine","volume":"60","author":"Nierenberg","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychores.2022.111122_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.12084su1c.02","article-title":"Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances","volume":"74","author":"Zajecka","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychores.2022.111122_bb0020","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"Fava","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0025","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","author":"Conradi","year":"2011","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S0033291701004214","article-title":"Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1994","volume":"31","author":"Addington","year":"2001","journal-title":"Psychol. Med."},{"issue":"2\u20133","key":"10.1016\/j.jpsychores.2022.111122_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0327(98)00138-4","article-title":"Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse","volume":"50","author":"Judd","year":"1998","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jpsychores.2022.111122_bb0040","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/appi.ajp.157.9.1501","article-title":"Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?","volume":"157","author":"Judd","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2022.111122_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpsychores.2022.111122_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/2047487312436452","article-title":"Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry","volume":"20","author":"Damen","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.jpsychores.2022.111122_bb0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archgenpsychiatry.2010.36","article-title":"Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome","volume":"67","author":"Davidson","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0060","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/ije\/dyg235","article-title":"Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City heart study","volume":"32","author":"Prescott","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.jpsychores.2022.111122_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpsychores.2009.07.013","article-title":"Depressive symptoms in persons with acute coronary syndrome: specific symptom scales and prognosis","volume":"68","author":"Doyle","year":"2010","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0070","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006842-199911000-00001","article-title":"Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue","volume":"61","author":"Irvine","year":"1999","journal-title":"Psychosom. Med."},{"issue":"4","key":"10.1016\/j.jpsychores.2022.111122_bb0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PSY.0000000000000570","article-title":"Residual symptoms after treatment for depression in patients with coronary heart disease","volume":"80","author":"Carney","year":"2018","journal-title":"Psychosom. Med."},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.jpsychores.2022.111122_bb0085","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2009.1487","article-title":"Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial","volume":"302","author":"Carney","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jpsychores.2022.111122_bb0090","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12742","article-title":"A randomized placebo-controlled trial of Omega-3 and sertraline in depressed patients with or at risk for coronary heart disease","volume":"80","author":"Carney","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychores.2022.111122_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpsychores.2016.07.011","article-title":"Clinical predictors of depression treatment outcomes in patients with coronary heart disease","volume":"88","author":"Carney","year":"2016","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jpsychores.2022.111122_bb0100","series-title":"BDI-II Manual","author":"Beck","year":"1996"},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.jpsychores.2022.111122_bb0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1176\/appi.ajp.2008.08081239","article-title":"Treatment-resistant depression and mortality after acute coronary syndrome","volume":"166","author":"Carney","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2022.111122_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PSY.0b013e3182405ac4","article-title":"Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?","volume":"74","author":"Carney","year":"2012","journal-title":"Psychosom. Med."},{"issue":"1\u20133","key":"10.1016\/j.jpsychores.2022.111122_bb0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jad.2013.02.008","article-title":"Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study","volume":"149","author":"Roest","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jpsychores.2022.111122_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychores.2022.111122_bb0130","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4088\/JCP.10m06419","article-title":"Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the genome-based therapeutic drugs for depression (GENDEP) study","volume":"72","author":"Uher","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychores.2022.111122_bb0135","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archpsyc.65.8.870","article-title":"Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features","volume":"65","author":"Rush","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychores.2022.111122_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","article-title":"Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design","volume":"78","author":"Trivedi","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.jpsychores.2022.111122_bb0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.148.8.997","article-title":"Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program","volume":"148","author":"Sotsky","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychores.2022.111122_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jad.2019.03.031","article-title":"Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials","volume":"250","author":"Noma","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jpsychores.2022.111122_bb0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamapsychiatry.2019.4815","article-title":"Individual differences in response to antidepressants: a Meta-analysis of placebo-controlled randomized clinical trials","volume":"77","author":"Maslej","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychores.2022.111122_bb0160","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","article-title":"Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors","volume":"60","author":"Papakostas","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychores.2022.111122_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4088\/JCP.v68n0211","article-title":"A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder","volume":"68","author":"Carney","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychores.2022.111122_bb0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2008.06.021","article-title":"Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial","volume":"169","author":"Kang","year":"2009","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.jpsychores.2022.111122_bb0175","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.biopsych.2005.03.030","article-title":"Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?","volume":"57","author":"Nelson","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jpsychores.2022.111122_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2011.12.015","article-title":"Symptom specificity in the acute treatment of major depressive disorder: a re-analysis of the treatment of depression collaborative research program","volume":"137","author":"Stewart","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jpsychores.2022.111122_bb0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/wps.20630","article-title":"The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis","volume":"18","author":"Boschloo","year":"2019","journal-title":"World Psychiatry"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239992200407X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239992200407X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:51:36Z","timestamp":1758369096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239992200407X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S002239992200407X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2022.111122","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptoms that remain after depression treatment in patients with coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2022.111122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111122"}}